Prof. Dr. ID: 52993

Martin Horstmann

graph of relations

Publications

  1. 2011
  2. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

    Escherich, G., Troeger, A. F., Gobel, U., Graubner, U., Pekrun, A., Jorch, N., Kaspers, G., Zimmermann, M., Zur Stadt, U., Kazemir, K., Pieters, R., Horstmann, M., Denboer, M. L. & Janka-Schaub, G., 2011, In: HAEMATOLOGICA. 96, 6, p. 854-862 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2010
  4. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.

    Escherich, G., Horstmann, M. A., Zimmermann, M., Janka-Schaub, G. E. & COALL study group, 01.02.2010, In: LEUKEMIA. 24, 2, p. 298-308 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.

    Zuurbier, L., Homminga, I., Calvert, V., Te Winkel, M. L., Buijs-Gladdines, J. G. C. A. M., Kooi, C., Smits, W. K., Sonneveld, E., Veerman, A. J. P., Kamps, W. A., Horstmann, M., Petricoin, E. F., Pieters, R. & Meijerink, J. P. P., 2010, In: LEUKEMIA. 24, 12, p. 2014-2022 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2009
  7. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

    Den, B., Monique, L., Slegtenhorst, V., Marjon, U., Menezes, D., Renée, X., Cheok, U., Meyling, H., Buijs-Gladdines, U., Jessica, G. C. A. M., Peters, U., Susan, T. C. J. M., Zutven, V., Laura, J. C. M., Beverloo, U., Berna, H., Spek, V. D., Peter, J., Escherich, G., Gaby, U., Horstmann, M., Martin, A., Janka-Schaub, G., Gritta, E., Kamps, U., Willem, A., Evans, U., William, E., Pieters, U. & Rob, U., 01.02.2009, In: LANCET ONCOL. 10, 2, p. 125-134 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. WT1 mutations in T-ALL.

    Tosello, V., Mansour, M. R., Barnes, K., Paganin, M., Sulis, M. L., Jenkinson, S., Allen, C. G., Gale, R. E., Linch, D. C., Palomero, T., Real, P., Murty, V., Yao, X., Richards, S. M., Goldstone, A., Rowe, J., Basso, G., Wiernik, P. H., Paietta, E., Pieters, R., Horstmann, M., Meijerink, J. P. P. & Ferrando, A. A., 2009, In: BLOOD. 114, 5, p. 1038-1045 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. 2008
  10. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].

    Bhojwani, D., Kang, H., Menezes, R. X., Yang, W., Sather, H., Moskowitz, N. P., Min, D-J., Potter, J. W., Harvey, R., Hunger, S. P., Seibel, N., Raetz, E. A., Pieters, R., Horstmann, M. A., Relling, M. V., den Boer, M. L., Willman, C. L., Carroll, W. L. & Children's Oncology Group Study, 20.09.2008, In: J CLIN ONCOL. 26, 27, p. 4376-4384 9 p., 27.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.

    Van Vlierberghe, P., Homminga, I., Zuurbier, L., Gladdines-Buijs, J., van Wering, E. R., Horstmann, M., Beverloo, H. B., Pieters, R. & Meijerink, J. P. P., 2008, In: LEUKEMIA. 22, 4, p. 762-770 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.

    Balgobind, U., Brian, V., Vlierberghe, V., Pieter, U., van Den, O., Ans, M. W., Beverloo, U., Berna, H., Terlouw-Kromosoeto, U., Joan, N. R., Wering, V., Elisabeth, R., Reinhardt, U., Dirk, U., Horstmann, M., Martin, U., Kaspers, U., Gertjan, J. L., Pieters, U., Rob, U., Zwaan, U., Michel, C., Heuvel-Eibrink, V. D., Marry, M., Meijerink, U. & Jules, P. P., 2008, In: BLOOD. 111, 8, p. 4322-4328 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.

    Van Vlierberghe, P., Beverloo, H. B., Buijs-Gladdines, J., van Wering, E. R., Horstmann, M., Pieters, R. & Meijerink, J. P. P., 2008, In: LEUKEMIA. 22, 7, p. 1434-1437 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.

    Pieter, V. V., van Grotel, M., Tchinda, J., Lee, C., Beverloo, H. B., Spek, V. D., Peter, J., Stubbs, A., Cools, J., Nagata, K., Fornerod, M., Horstmann, M., Horstmann, M., Wering, V., Elisabeth, R., Soulier, J., Pieters, R. & Meijerink, J. P. P., 2008, In: BLOOD. 111, 9, p. 4668-4680 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. 2007
  16. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations.

    Metzner, A., Horstmann, M., Fehse, B., Ortmeyer, G., Niemeyer, C. M., Stocking, C., Mayr, G. W. & Jücker, M., 2007, In: GENE THER. 14, 8, p. 699-703 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. 2006
  18. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.

    Grotel, V., Martine, U., Meijerink, U., Jules, P. P., Beverloo, U., Berna, H., Langerak, U., Anton, W., Buys-Gladdines, U., Jessica, G. C. A. M., Schneider, U., Pauline, U., Poulsen, U., Tim, S., Den, B., Monique, L., Horstmann, M., Martin, U., Kamps, U., Willem, A., Veerman, U., Anjo, J. P., Wering, V., Elisabeth, R., Noesel, V., Max, M., Pieters, U. & Rob, U., 01.09.2006, In: HAEMATOLOGICA. 91, 9, p. 1212-1221 10 p., 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains.

    Dierck, K., Machida, K., Voigt, A., Thimm, J., Horstmann, M., Fiedler, W., Mayer, B. J. & Nollau, P., 2006, In: NAT METHODS. 3, 9, p. 737-744 8 p., 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2005
  21. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels

    Horstmann, M., Merseburger, A. S., von der Heyde, E., Serth, J., Wegener, G., Mengel, M., Feil, G., Hennenlotter, J., Nagele, U., Anastasiadis, A., Bokemeyer, C., Stenzl, A. & Kuczyk, M., 11.2005, In: J CANCER RES CLIN. 131, 11, p. 715-22 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.

    Horstmann, M., Hassenpflug, W-A., Udo, Z. S., Escherich, G., Janka-Schaub, G. & Kabisch, H., 2005, In: HAEMATOLOGICA. 90, 12, p. 1701-1703 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.

    Stam, R. W., Boer, D., Monique, L., Schneider, P., Horstmann, M., Horstmann, M., Beverloo, H. B., van der Voort, E., Valsecchi, M. G., de Lorenzo, P., Sallan, S. E., Armstrong, S. A. & Pieters, R., 2005, In: BLOOD. 106, 7, p. 2484-2490 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. 2004
  25. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.

    Du, J., Widlund, H. R., Horstmann, M., Ramaswamy, S., Ross, K., Huber, W. E., Nishimura, E. K., Golub, T. R. & Fisher, D. E., 2004, In: CANCER CELL. 6, 6, p. 565-576 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. 2003
  27. Infantile cobalamin deficiency with cerebral lactate accumulation and sustained choline depletion.

    Horstmann, M., Neumaier-Probst, E., Lukacs, Z., Steinfeld, R., Ullrich, K. & Kohlschütter, A., 2003, In: NEUROPEDIATRICS. 34, 5, p. 261-264 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.

    Du, J., Miller, A. J., Widlund, H. R., Horstmann, M., Ramaswamy, S. & Fisher, D. E., 2003, In: AM J PATHOL. 163, 1, p. 333-343 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. 2002
  30. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor

    Widlund, H. R., Horstmann, M. A., Price, E. R., Cui, J., Lessnick, S. L., Wu, M., He, X. & Fisher, D. E., 16.09.2002, In: J CELL BIOL. 158, 6, p. 1079-87 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.

    McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y-L., Ramaswamy, S., Avery, W., Ding, H-F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R. & Fisher, D. E., 2002, In: CELL. 109, 6, p. 707-718 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.

    Kröger, N., Zabelina, T., Renges, H., Krüger, W., Kordes, U., Rischewski, J., Schrum, J., Horstmann, M., Ayuketang Ayuk, F., Erttmann, R., Kabisch, H. & Zander, A. R., 2002, In: ANN HEMATOL. 81, 11, p. 627-631 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. 2001
  34. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family.

    Motyckova, G., Weilbaecher, K. N., Horstmann, M., Rieman, D. J., Fisher, D. Z. & Fisher, D. E., 08.05.2001, In: P NATL ACAD SCI USA. 98, 10, p. 5798-5803 6 p., 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. 2000
  36. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

    Wu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M., Wells, A. G., Price, E. R., Fisher, D. Z. & Fisher, D. E., 2000, In: GENE DEV. 14, 3, p. 301-312 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. 1999
  38. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients.

    Dürken, M., Horstmann, M., Bieling, P., Erttmann, R., Kabisch, H., Löliger, C., Schneider, E. M., Hellwege, H. H., Krüger, W., Kröger, N., Zander, A. R. & Janka, G. E., 01.09.1999, In: BRIT J HAEMATOL. 106, 4, p. 1052-1058 7 p., 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. 1998
  40. Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3.

    Weilbaecher, K. N., Hershey, C. L., Takemoto, C. M., Horstmann, M., Hemesath, T. J., Tashjian, A. H. & Fisher, D. E., 02.03.1998, In: J EXP MED. 187, 5, p. 775-785 11 p., 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome.

    Price, E. R., Horstmann, M., Wells, A. G., Weilbaecher, K. N., Takemoto, C. M., Landis, M. W. & Fisher, D. E., 1998, In: J BIOL CHEM. 273, 49, p. 33042-33047 49.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Treatment and long-term outcome of pineal nongerminomatous germ cell tumors.

    Knappe, U. J., Bentele, K. H. P., Horstmann, M. & Herrmann, H. D., 1998, In: PEDIATR NEUROSURG. 28, 5, p. 241-245 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. 1997
  44. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.

    Anderegg, B., Horstmann, M. & Kabisch, H., 1997, In: CANCER GENE THER. 4, 2, p. 84-90 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Frequent reduction or loss of DCC gene expression in human osteosarcoma.

    Horstmann, M., Pösl, M., Scholz, R. B., Anderegg, B., Simon, P., Baumgaertl, K., Delling, G. & Kabisch, H., 1997, In: BRIT J CANCER. 75, 9, p. 1309-1317 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.

    Zander, A. R., Berger, C., Kröger, N., Stockshläder, M., Krüger, W., Horstmann, M., Grimm, J., Zeller, W., Kabisch, H., Erttmann, R., Schönrock, P., Kuse, R., Braumann, D., Illiger, H. J., Fiedler, W., de Witt, M., Hossfeld, K. D. & Weh, H. J., 1997, In: CLIN CANCER RES. 3(12 Pt 2), p. 2671-2675

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay.

    Anderegg, B., Horstmann, M., Ernst, M. & Kabisch, H., 1997, In: PEDIATR HEMAT ONCOL. 14, 4, p. 349-358 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. 1996
  49. Early toxicity of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation.

    Horstmann, M., Kroschke, G., Stockschläder, M., Betker, R., Krüger, W., Erttmann, R., Kabisch, H. & Zander, A., 1996, In: PEDIATR HEMAT ONCOL. 13, 1, p. 45-53 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values.

    Krüger, W., Sobottka, I., Stockschläder, M., Mross, K., Hoffknecht, M., Rüssmann, B., Horstmann, M., Betker, R. & Zander, A., 1996, In: SCAND J INFECT DIS. 28, 3, p. 313-316 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(11;18;19).

    Horstmann, M., Argyriou-Tirita, A., Borkhardt, A., Kabisch, H., Kapaun, P., Winkler, K. & Haas, O. A., 1996, In: CANCER GENET-NY. 88, 2, p. 103-109 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Use of cryopreserved bone marrow in unrelated allogeneic transplantation.

    Stockschläder, M., Krüger, W., Tom Dieck, A., Horstmann, M., Altnöder, M., Löliger, C., Fiedler, W., Hoffknecht, M., Erttmann, R. & Zander, A., 1996, In: BONE MARROW TRANSPL. 17, 2, p. 197-199 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. 1995
  54. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.

    Horstmann, M., Stockschläder, M., Krüger, W., Hoffknecht, M., Betker, R., Kabisch, H. & Zander, A., 01.08.1995, In: ANN HEMATOL. 71, 2, p. 77-81 5 p., 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia transplanted with bone marrow from HLA-identical related donors

    Horstmann, M., Stockschläder, M., Kabisch, H. & Zander, A., 01.03.1995, In: BLOOD. 85, 5, p. 1404-5 2 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.

    Krüger, W., Stockschläder, M., Rüssmann, B., Berger, C., Hoffknecht, M., Sobottka, I., Kohlschütter, B., Kroschke, G., Kröger, N. & Horstmann, M., 1995, In: BRIT J HAEMATOL. 91, 3, p. 684-690 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  57. 1994
  58. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment.

    Horstmann, M., Erttmann, R. & Winkler, K., 1994, In: LANCET. 343, 8905, p. 1098-1099 8905.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next